Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia: A Phase 2 Study. Xie X, Shi X, Zhang Y, Su S, et al. J Am Coll Cardiol 2025;85:1821-1835.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xie X, Shi X, Zhang Y, Su S, et al. Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia: A Phase 2 Study. J Am Coll Cardiol 2025;85:1821-1835.
PMID: 40167414